Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
Read More
We exist to help people of all ages, from day one and every day after.
Learn more about our FDA-approved medicine for pediatric patients with relapsed or refractory pediatric low-grade glioma (pLGG).
Read More
Read More
Read More